Juvena Therapeutics Awarded CIRM Grant to Advance Myotonic Dystrophy Type 1 Therapeutic

https://www.prnewswire.com/news-releases/juvena-therapeutics-awarded-highly-competitive-cirm-grant-to-advance-lead-program-juv-161-to-treat-myotonic-dystrophy-type-1-301473380.html
Join the IPIRA Mailing List

 

 
 
 
 

 

Accessibility | Nondiscrimination | Privacy